Health Affairs, 24, no. 1 (2005): 41 doi: 10.1377/hlthaff.24.1.41 © 2005 by Project HOPE	New Online   Senate Health Reform Bill   Rewarding Providers   Public Option Policy Brief   Health Reform & Abortion   Delivery System Reform

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Case Studies

PROLOGUE

Evidence-Based Medicine Case Studies

PROLOGUE: Clinical trials for evidence-based medicine (EBM) can stop traditional therapies dead in their tracks; likewise, they can introduce new drugs and procedures to medical practice. In the 1990s clinical trials disproved the benefits of anti-arrhythmic drugs to prevent heart attacks in patients with a history of prior heart attack. It was only from the findings of clinical trials that these therapies were found to do more harm than good. These findings have spurred the EBM community to promote clinical trials, particularly randomized controlled trials (RCTs), for the introduction of new drugs, techniques, and devices. Papers in this section look . . . [Full Text of this Article]

                      What's this?